Diabetic Clinical Trial
Official title:
Prevention of Foot Ulcer Recurrence in People With Diabetes Using an In-shoe Pressure Measurement Technology: A Randomised Control Trial Feasibility Study
Insoles are designed to reduce increased loads and re-ulceration risk in patients with
diabetes. The investigators previous research findings suggest that an instant insole
solution may benefit some, but effectiveness is difficult to predict. The investigators
propose a feasibility study using in-shoe pressure analysis to optimise the protective
effect of insoles and footwear with the aim of reducing re-ulceration rates.
Early indications from exploratory case studies within the real world clinical setting
suggest that by implementing the investigators previous published research findings the
investigators can optimise effectiveness and reduce outcome variability of protective
footwear and insoles provided to patients at risk of re-ulceration.
However a further randomised control trial is necessary to evaluate the effectiveness of
in-shoe pressure analysis in reducing re-ulceration rates within the NHS setting. The
proposed feasibility study will recruit 20 participants from the multidisaplinary diabetic
foot clinic Derriford Hospital and allocate them to either 1) Routine insoles and footwear
provision or 2) Routine insole and footwear provision, and temporary insole provision with
optimisation. The findings from the feasibility study will inform protocol development for a
larger clinical trial. The results of the feasibility study will be used to strengthen a
protocol for a grant application to conduct the main RCT. A secondary output from the pilot
study will be the dissemination of findings in a peer reviewed journal and at conference.
Status | Not yet recruiting |
Enrollment | 20 |
Est. completion date | January 2015 |
Est. primary completion date | January 2015 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 30 Years and older |
Eligibility |
Inclusion Criteria: - Participant is willing and able to give informed consent for participation in the study. - Male or Female, aged 30 years or above - Diagnosed with Diabetes Mellitus - Recently healed/healing target ulcer on the weight-bearing surface of the foot - Neuropathic (Mild to moderate DPN defined as insensitivity of a 10 g monofilament at 1-3 sites in the following locations: hallux, 1st, 3rd, and 5th metatarsal heads (Boulton AJ, Armstrong DG, Albert SF, Frykberg RG, Hellman R, Kirkman MS, Lavery LA, Lemaster JW, Mills JL Sr, Mueller MJ, Sheehan P, Wukich DK: Comprehensive foot examination and risk assessment: a report of the task force of the foot care interest group of the American Diabetes Association, with endorsement by the American Association of Clinical Endocrinologists. Diabetes Care 2008;31:1679-1685) - Able (in the Investigators opinion) and willing to comply with all study requirements Exclusion Criteria: - The participant may not enter the study if ANY of the following apply: Any other significant disease or disorder which, in the opinion of the Investigator, may either put the participants at risk because of participation in the study, or may influence the result of the study, or the participant's ability to participate in the study. - None healing foot ulcer at another site that requires targeted off-loading. - Unable to walk 5 metres with/without walking aid - Peripheral vascular disease (non-re-constructible vascular disease as determined by arterial duplex and clinically assessed by a vascular consultant) - Unwilling to wear therapeutic footwear - Where amputation has been part of the current episode of care and includes ulceration site. |
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention
Country | Name | City | State |
---|---|---|---|
United Kingdom | Derriford Hospital | Plymouth | Devon |
Lead Sponsor | Collaborator |
---|---|
University of Plymouth | Plymouth Hospitals NHS Trust |
United Kingdom,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | ulcer recurrence rates | 6 months | ||
Secondary | peak pressure reduction with the addition of the intervention | Issue and 6 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT05471687 -
Evaluation of the Functional Impact of Coronary Stenoses in Diabetics by Spectral CT
|
N/A | |
Recruiting |
NCT04353869 -
Targeting Glutamine Metabolism to Prevent Diabetic Cardiovascular Complications
|
||
Recruiting |
NCT05614115 -
Safety, Tolerability, and Feasibility of Empagliflozin Therapy in Dialysis-dependent ESKD
|
Phase 1 | |
Completed |
NCT04558775 -
TEWL Biomarker Study for Diabetic Foot Ulcer Recurrence
|
||
Not yet recruiting |
NCT03782155 -
Effect of Supplementation With HMB and Glutamine in Wound Healing on Bloody Areas
|
Phase 4 | |
Completed |
NCT05994651 -
The Effect of the Tidal Model in Diabetes Patients
|
N/A | |
Completed |
NCT00256945 -
Surface Roughness of a Dental Restorative Material and Biofilm Formation
|
Phase 1 | |
Completed |
NCT04288050 -
Evaluation of Glycemic Profiles in Diabetic Patients on Dialysis Under Insulin Balsal-bolus Protocol, Using Freestyle Libre
|
||
Completed |
NCT01345500 -
UCSD Take Charge Study
|
N/A | |
Recruiting |
NCT01295385 -
Contribution Of Nuclear Magnetic Resonance Imaging In The Study Of Diabetic Cardiomyopathy
|
N/A | |
Completed |
NCT00387452 -
Exercise and Cardiovascular Control During Upright Tilt in Older Adults With Type 2 Diabetes
|
N/A |